Tradestie Institutional Equity Comparison Engine
PRTO vs TENX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
TENX Overall Edge
TENX Captures Institutional Edge (2โ2 Pillars ยท 8โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Tenax Therapeutics, Inc. (TENX) driven by superior Valuation, Growth & Margin while PRTO counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, PRTO trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus TENX at 0.3x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, PRTO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against TENX sits in BREAKDOWN (24th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
TENX
PRTO N/M vs TENX 0.3x Fwd P/E
Growth & Margin Winner
TENX
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner
PRTO
1Y -3.4% vs -82.9% ยท 52W Pos 0% vs 0%
Options & Structure Winner
PRTO
UNCLASSIFIED (N/A IV) vs BREAKDOWN (24th %ile IV)
PRTO
US Equity
PRTO
Institutional Equity
$24.45
-3.36% 1D
Market Cap
N/A
1M Return
-9.56%
1Y Return
-3.39%
Forward P/E
N/M
Unified AI Score
33.3 / 100
SELL
Tech 12.0
Fund 36.0
Flow 50.0
Mom 34.0
TENX
NASDAQ
Tenax Therapeutics, Inc.
Pharmaceutical Preparations
$1.25
-10.07% 1D
Market Cap
$63.3M
1M Return
-28.98%
1Y Return
-82.92%
Forward P/E
0.3x
Unified AI Score
45.5 / 100
HOLD
Tech 33.0
Fund 57.0
Flow 66.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
PRTO -3.39%
TENX -82.92%
Spread: +87.68 pp (PRTO Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
PRTO TTM Op. Margin: N/A
TENX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PRTO vs TENX. Trailing 12-month operating profitability (PRTO N/A vs TENX 0.0%) and valuation multiples (PRTO N/M vs TENX 0.3x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PRTO | TENX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $63.3M | Larger Scale | TENX |
| Trailing P/E Ratio Valuation | N/M | 0.3x | Lower Multiple | TENX |
| Forward P/E Ratio Valuation | N/M | 0.3x | Lower Multiple | TENX |
| Revenue Growth (YoY) Growth | N/A | +0.0% | Higher Growth | TENX |
| Operating Margin (TTM) Profitability | N/A | 0.0% | Higher Margin | TENX |
| Net Profit Margin Profitability | N/A | 0.0% | Higher Margin | TENX |
| Return on Equity (ROE) Capital Efficiency | N/A | -64.2% | Higher ROE | TENX |
| 52-Week Range Position Momentum | 0% ($24โ$29) | 0% ($1โ$19) | Stronger Trend | Tie |
| Beta / 30D Volatility Risk Regime | 0.89ฮฒ ยท 21% Vol | 1.42ฮฒ ยท 75% Vol | Lower Realized Risk | PRTO |
| Unified Institutional Score Composite Signal | 33.3 / 100 (SELL) | 45.5 / 100 (HOLD) | Higher Composite | TENX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full PRTO vs TENX Buy Guide
PRTO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
TENX
BREAKDOWN
95d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
24th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither PRTO nor TENX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.